- Title
- Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment
- Creators
- Malin Hultcrantz - Memorial Sloan Kettering Cancer CenterEven Holth Rustad - Memorial Sloan Kettering Cancer CenterVenkata Yellapantula - Memorial Sloan Kettering Cancer CenterMaria Arcila - Memorial Sloan Kettering Cancer CenterCaleb Ho - Memorial Sloan Kettering Cancer CenterMustafa H Syed - Memorial Sloan Kettering Cancer CenterElli Papaemmanuil - Memorial Sloan Kettering Cancer CenterYanming Zhang - Memorial Sloan Kettering Cancer CenterFrancesco Maura - Memorial Sloan Kettering Cancer CenterOla Landgren - Memorial Sloan Kettering Cancer CenterCarl Ola Landgren - Miller School of Medicine
- Publication Details
- Blood cancer journal (New York), Vol.10(7), pp.76-76
- Grant note
- 2015-00564 / Vetenskapsrådet (Swedish Research Council) P30 CA008748 / NCI NIH HHS
- Academic Unit
- Miller School of Medicine; UMMG Department of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 32699232
- Record Identifier
- 991031714170902976
Journal article
Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment
Blood cancer journal (New York), Vol.10(7), pp.76-76
2020-07-22
PMID: 32699232
Metrics
8 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.130 Lymphomas
- 1.130.617 Multiple Myeloma
- Web Of Science research areas
- Hematology
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites